secwatch.observer — SEC 8-K summary
======================================

Issuer:     Prelude Therapeutics Inc (PRLD)
CIK:        0001678660
Form:       8-K
Filed at:   2026-01-09T23:59:59+00:00
Accession:  0001193125-26-008280
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Prelude Therapeutics furnishes investor presentation; no material new information disclosed
--------------------------------------------------------------------------------

- Filed an investor presentation dated January 2026 for use in investor meetings starting Jan 9.
- The presentation includes forward-looking statements and general corporate overview.
- No specific new clinical data, financial results, or corporate milestones were released.
- The filing is a routine Regulation FD disclosure; presentation content not provided in full detail.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1678660/000119312526008280/0001193125-26-008280-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1678660/000119312526008280/prld-20260109.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-008280

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer